Status:
UNKNOWN
The Safety Outcomes of 27 Gauge Vitrectomy for Posterior Segment Disease in High Myopia
Lead Sponsor:
National Taiwan University Hospital
Collaborating Sponsors:
Alcon Research
Conditions:
Wound Complication
High Myopia
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
In recent decade, a major improvement in vitreoretinal surgery was the use of small gauge surgical systems that improved the safety of vitrectomy and also reduced the surgical time. However, there wer...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Highly myopic patients (axial length 26\~31mm)
- Diagnosed with vitreoretinal pathology that require vitrectomy
- Never received vitrectomy before
- Exclusion criteria:
- Surgical planning including scleral buckling during operation
- Surgical planning including combined phacoemulsification
- Surgical planning including the use of silicone oil and/or perfluorocarbon liquid
- Previous ocular surgery involving conjunctival manipulation and scarring such as pterygium removal/trabeculectomy
- Previous vitrectomy
- Previous ocular trauma involving corneal/corneoscleral/scleral/conjunctival full thickness laceration
- Medical history with known connective tissue disease(s)
- Age younger than 20 years old
Exclusion
Key Trial Info
Start Date :
April 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2021
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT04360603
Start Date
April 1 2020
End Date
August 1 2021
Last Update
April 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100